TR200000988T2 - Bakteri kolonizasyonunun kontrol edilmesi için bileşimler - Google Patents

Bakteri kolonizasyonunun kontrol edilmesi için bileşimler

Info

Publication number
TR200000988T2
TR200000988T2 TR2000/00988T TR200000988T TR200000988T2 TR 200000988 T2 TR200000988 T2 TR 200000988T2 TR 2000/00988 T TR2000/00988 T TR 2000/00988T TR 200000988 T TR200000988 T TR 200000988T TR 200000988 T2 TR200000988 T2 TR 200000988T2
Authority
TR
Turkey
Prior art keywords
enzyme
anchor
bacterial
compositions
complex
Prior art date
Application number
TR2000/00988T
Other languages
English (en)
Inventor
A. Budny John
Original Assignee
Pharmacal Biotechnologies Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacal Biotechnologies Inc. filed Critical Pharmacal Biotechnologies Inc.
Publication of TR200000988T2 publication Critical patent/TR200000988T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Bakteri büyümesi/kolonizasyonunun kontrol edilmesi için bir bilesim temin edilmistir. Bilesim, bir enzimi, bir enzim-ankor kompleksini olusturmak üzere enzime baglanmis bir ankor molekülünü içermektedir, ankor, bir bakteri kolonisine yakin bir alt-tabakaya baglanabilmektedir. Alt-tabakaya baglanma, bakteri kolonisinin kompleksin etkililigini arttirmak üzere mevcut oldugu kisimda, enzim-ankor kompleksinin tutulma süresini uzatmaktadir. Bulus, ayni zamanda, agiz boslugunda bakteri plakinin kolonizasyonunun kontrol edilmesi için bir yöntem olmanin yanisira, agiz boslugu içinde bakteri kolonilerinin çogalmasinin kontrol edilmesi için bir bilesimin olusturulmasi için bir yöntemdir.
TR2000/00988T 1997-10-16 1998-10-13 Bakteri kolonizasyonunun kontrol edilmesi için bileşimler TR200000988T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/951,393 US5871714A (en) 1997-10-16 1997-10-16 Compositions for controlling bacterial colonization

Publications (1)

Publication Number Publication Date
TR200000988T2 true TR200000988T2 (tr) 2000-08-21

Family

ID=25491643

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00988T TR200000988T2 (tr) 1997-10-16 1998-10-13 Bakteri kolonizasyonunun kontrol edilmesi için bileşimler

Country Status (22)

Country Link
US (1) US5871714A (tr)
EP (1) EP1023084A1 (tr)
JP (1) JP2001519404A (tr)
KR (1) KR20010015757A (tr)
CN (1) CN1276732A (tr)
AU (1) AU742762B2 (tr)
BR (1) BR9812923A (tr)
CA (1) CA2306459A1 (tr)
CU (1) CU22838A3 (tr)
CZ (1) CZ20001237A3 (tr)
EA (1) EA002244B1 (tr)
HU (1) HUP0100016A2 (tr)
ID (1) ID24368A (tr)
IL (1) IL135628A0 (tr)
IN (1) IN2002DE00891A (tr)
MX (1) MXPA00003618A (tr)
NO (1) NO20001885L (tr)
NZ (1) NZ503974A (tr)
PL (1) PL339900A1 (tr)
TR (1) TR200000988T2 (tr)
WO (1) WO1999018999A1 (tr)
ZA (1) ZA989024B (tr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159447A (en) * 1997-10-16 2000-12-12 Pharmacal Biotechnologies, Llc Compositions for controlling bacterial colonization
US20020022005A1 (en) * 1997-10-16 2002-02-21 Budny John A. Compositions for treating cystic fibrosis
US6830745B1 (en) * 1997-10-16 2004-12-14 Pharmacal Biotechnologies, Llc Compositions for treating biofilm
US5972311A (en) * 1998-01-26 1999-10-26 Duke University Method of preventing dental caries and other oral lesions
DE19909770A1 (de) 1999-03-05 2000-09-07 Werner Lubitz Bakterienghosts als Träger- und Targetingvehikel
US8522127B2 (en) 2001-07-16 2013-08-27 Robert G. Adamson, III Allowing operating system access to non-standard fonts in a network document
US10810355B1 (en) 2001-07-16 2020-10-20 Clantech, Inc. Allowing operating system access to non-standard fonts in a network document
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
US20050014932A1 (en) * 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
US7220405B2 (en) * 2003-09-08 2007-05-22 E. I. Du Pont De Nemours And Company Peptide-based conditioners and colorants for hair, skin, and nails
EP1812550A2 (en) * 2004-10-20 2007-08-01 Iogenetics, Llc Biocides
MX2009005783A (es) * 2006-12-01 2009-10-28 Laclede Inc Uso de enzimas hidroliticas y oxidativas para disolver bio-peliculas en los oidos.
WO2009014905A1 (en) * 2007-07-25 2009-01-29 3M Innovative Properties Company Film forming dental compositions and related methods
WO2009014907A1 (en) 2007-07-25 2009-01-29 3M Innovative Properties Company Therapeutic dental composition and related methods
EP2092834A1 (en) * 2008-02-19 2009-08-26 Innopact B.V. Methods and compositions of sphingolipid for preventing treating microbial infections
CA2822422C (en) 2010-12-20 2021-02-02 E. I. Du Pont De Nemours And Company Enzymatic peracid generation for use in oral care products
WO2012087966A2 (en) 2010-12-20 2012-06-28 E. I. Du Pont De Nemours And Company Targeted perhydrolases
CN102219597B (zh) * 2011-04-11 2013-09-11 北京中农瑞利源高科技发展有限公司 酶控剂和酶控系列肥料及其在农业中的应用
US10420822B2 (en) 2011-06-13 2019-09-24 Ziolase, Llc Compositions and methods to prevent and treat biofilms
US20120315260A1 (en) * 2011-06-13 2012-12-13 Svetlana A. Ivanova Compositions and Methods to Prevent and Treat Biofilms
IN2012DE01792A (tr) 2012-06-11 2015-10-16 Council Scient Ind Res
KR102360720B1 (ko) * 2015-06-30 2022-02-10 (주)아모레퍼시픽 프라그 기질 용해제
CN111551416B (zh) * 2020-03-22 2021-08-06 华南理工大学 一种基于细胞膜磷脂酰丝氨酸荧光染色的细菌类凋亡评价方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1373487A (en) * 1970-10-26 1974-11-13 Guggenheim B Enzymes their preparation and uses
US4335101A (en) * 1971-08-10 1982-06-15 Merck & Co., Inc. Oral hygiene enzymes and method for preparation
JPS5536317B2 (tr) * 1972-04-22 1980-09-19
GB1433593A (en) * 1972-06-09 1976-04-28 Royal College Of Surgeons Conjugates
US4138476A (en) * 1977-08-03 1979-02-06 The United States Of America As Represented By The Secretary Of The Navy Plaque dispersing enzymes as oral therapeutic agents by molecular alteration
JPS57165312A (en) * 1981-04-03 1982-10-12 Handai Biseibutsubiyou Kenkyukai Production of oral composition
JPH0641424B2 (ja) * 1984-11-06 1994-06-01 ライオン株式会社 う蝕予防剤
US5306639A (en) * 1985-03-20 1994-04-26 Aizo Matsushiro DNA encoding glucanase enzymes
US4737359A (en) * 1985-04-18 1988-04-12 Colgate-Palmolive Company Control of dental plaque and caries using emulsan
GB8528761D0 (en) * 1985-11-22 1985-12-24 Axon Healthcare Ltd Enzyme-coupled antibodies
AU5546090A (en) * 1989-06-30 1991-01-17 Brunswick Corporation Antibody-lactate oxidase conjugates
JPH0363215A (ja) * 1989-07-29 1991-03-19 Nakano Vinegar Co Ltd 歯垢分解組成物
GB9021671D0 (en) * 1990-10-05 1990-11-21 Unilever Plc Delivery of agents
AU642980B2 (en) * 1990-03-21 1993-11-04 Quest International B.V. Ultilization of enzymes
AU642979B2 (en) * 1990-03-21 1993-11-04 Quest International B.V. Utilization and delivery of enzymes
US5202113A (en) * 1990-04-30 1993-04-13 The United States Of America As Represented By The Department Of Health And Human Services Plaque-inhibiting protein from bacteroides loeschei and methods for using the same
US5362480A (en) * 1991-12-31 1994-11-08 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions containing amino sugars as antiplaque agents
US5409902A (en) * 1991-12-31 1995-04-25 Lever Brothers Company Oral hygiene compositions containing glyceroglycolipids as antiplaque compounds
US5320831A (en) * 1992-12-30 1994-06-14 The Procter & Gamble Company Oral compositions
US5490978A (en) * 1993-10-15 1996-02-13 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Block copolymers of polysaccharides and polyalkylene oxides
EP0824019B1 (en) * 1996-08-13 2002-11-20 Quest International B.V. Inhibition or reduction of oral malodour

Also Published As

Publication number Publication date
WO1999018999A1 (en) 1999-04-22
ID24368A (id) 2000-07-13
JP2001519404A (ja) 2001-10-23
IN2002DE00891A (tr) 2005-01-21
PL339900A1 (en) 2001-01-15
HUP0100016A2 (hu) 2001-05-28
KR20010015757A (ko) 2001-02-26
BR9812923A (pt) 2000-08-08
CZ20001237A3 (cs) 2000-08-16
ZA989024B (en) 1999-04-07
CN1276732A (zh) 2000-12-13
AU9802898A (en) 1999-05-03
NO20001885D0 (no) 2000-04-12
EA200000422A1 (ru) 2000-10-30
MXPA00003618A (es) 2001-10-01
US5871714A (en) 1999-02-16
CU22838A3 (es) 2006-04-18
IL135628A0 (en) 2001-05-20
EP1023084A1 (en) 2000-08-02
NZ503974A (en) 2002-05-31
AU742762B2 (en) 2002-01-10
NO20001885L (no) 2000-06-14
CA2306459A1 (en) 1999-04-22
EA002244B1 (ru) 2002-02-28

Similar Documents

Publication Publication Date Title
TR200000988T2 (tr) Bakteri kolonizasyonunun kontrol edilmesi için bileşimler
MX2007006866A (es) Composiciones que tiene una alta eficacia antiviral y antibacterial.
MXPA02012326A (es) Peptidos quimicamente modificados, composiciones y metodos para su produccion y uso.
IL121895A (en) Slow release composition for oral consumption containing a zinc compound an amino acid and copper compound
BG103977A (en) Low molecular rotamase enzymic activity inhibitors
GEP20022617B (en) 3-Heterocyclic YL-Substituted Benzoyl Derivatives, Method for Their Production, Herbicidal Preparation and Method for Undesirable Plants Control
UA85993C2 (ru) Конъюгат, который содержит бактериальный суперантиген и антительную составную, фармацевтическая композиция, которая его содержит, и способ лечения рака у млекопитающего
WO2002072777A3 (en) A novel antagonistic yeast useful in controlling spoilage of agricultural produce, methods of use thereof and compositions containing same
MY132115A (en) Novel thrombin inhibitors
AU3594900A (en) Compositions for controlling bacterial colonization
UA41275C2 (uk) Гербіцидна композиція та спосіб контролю росту небажаних рослин
EP0743311A4 (en) FLAVANONOL DERIVATIVES AND COMPOSITION CONTAINING SUCH DERIVATIVES SUITABLE FOR FEEDING HAIR AND STIMULATING THEIR GROWTH
DK1483366T3 (da) Antimikrobiel sammensætning
EP1074252A3 (en) Composition comprising theanine for suppressing behaviour problems of pets
UA42009C2 (uk) Фунгіцидний двокомпонентний препарат та спосіб боротьби та запобігання ураженню грибами рослин,їх частин або місць їх зростання
DE60334846D1 (de) VERWENDUNG von LIGNINPEROXIDASE ZUR HAUT- UND HAARAUFHELLUNG
AU8347198A (en) Antifungal composition
AU3222195A (en) Organic compounds
CA2455042A1 (en) Method of reducing hair growth by applying alpha-difluoromethylornithine
FI964237A (fi) Mikrobiologisen vaikutuksen alaisen korroosion ja värjäytymisen ennaltaehkäisyyn/lieventämiseen käyttökelpoisia boraatteja
MXPA05013250A (es) Composicion dental de dulce en contra de la placa.
WO2002102835A8 (en) Novel antimicrobial compounds
MX9605346A (es) Compuesto antimicrobianos con velocidad rapida de eliminacion.
AU2473199A (en) Method and composition for controlling microbial growth using bromonitrostyrene and peracetic acid
EP1133991A4 (en) BACTERIOSTATIC COMPOSITIONS AGAINST SALMONELLA